Chardan Healthcare Acquisition 2 Corp.

Completed

Follow

Detailed Information

Information on this SPAC.

Sponsors: Chardan Investments 2
Underwriters: Chardan Capital Markets
B. Riley
Focus: Healthcare
SEC Filings: 1799850
Public Embarc Page: https://embarc.com/capital/spac/1799850/CHAQ/chardan-healthcare-acquisition
IPO Ticker: CHAQ

SPAC Leadership

Information on the SPAC leadership.

Executive Chairman of the Board and Chief Science OfficerGbola Amusa
President, Chief Executive Officer and DirectorJonas Grossman
Chief Financial Officer, Head of Strategy and DirectorGeorge Kaufman
Chief Operating OfficerGuy Barudin
DirectorIsaac Manke
DirectorMichael Rice
DirectorRichard Giroux
DirectorMatthew Rossen
DirectorR.A. Session II

Target Information

Information on the SPAC target for merger.

Company: Renovacor Inc
Presentation: Investor Presentation (SEC) on 2021-08-19
New Ticker: RCOR RCOR.WS
Description: Renovacor is "an early-stage biotechnology company developing AAV-based gene therapies for devastating cardiovascular and central nervous system (CNS) diseases resulting from BAG3 gene dysfunction."